47 studies found for:    ovarian,cancer,detection | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer
Conditions: Ovarian Cancer Stage III;   Ovarian Cancer Stage IV
Intervention: Device: PET/CT
22 Recruiting Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
Conditions: Mutation;   Neoplasms
Intervention: Genetic: ctDNA Analysis for the Detection of Genetic Mutations
23 Recruiting Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
Conditions: Ovarian Epithelial Cancer;   Carcinoma in Situ;   Ovarian Cancer
Intervention: Procedure: Lavage of the Cavum uteri and proximal Fallopian tubes
24 Unknown  Sentinel Node in Ovarian Cancer
Conditions: Ovarian Cancer;   Sentinel Node
Intervention: Procedure: blue dye and radioactive tracer
25 Not yet recruiting Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   High Grade Ovarian Serous Adenocarcinoma;   Ovarian Endometrioid Tumor;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Drug: Cediranib Maleate;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib;   Other: Pharmacological Study
26 Not yet recruiting Autologous Dendritic Cell-Tumor Cell Immunotherapy for Advanced Epithelial Ovarian Carcinomas
Conditions: Stage III Ovarian Carcinoma;   Stage IV Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Biological: ovapuldencel-T;   Biological: MC: Autologous PBMCs in GM-CSF
27 Unknown  Mesothelin as a New Tumor Marker for Ovarian Cancer
Condition: Ovarian Cancer
28 Not yet recruiting Fermented Wheat Germ Extract in Women With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Fermented Wheat Germ Extract (FWGE);   Drug: Placebo;   Procedure: Planned Surgery;   Other: Quality of Life (QoL) Surveys: FACT-O
29 Recruiting Blood Test for Ovarian Cancer Associated Auto Antibodies
Condition: Ovarian Cancer
30 Unknown  Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses
Condition: Ovarian Tumor
Intervention: Procedure: Contrast-enhanced ultrasound
31 Not yet recruiting DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
32 Not yet recruiting Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial Cancer
Condition: Ovarian Neoplasms
33 Recruiting Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE)
Conditions: Cancer of Digestive System;   Ovarian Cancer
Intervention: Device: confocal laser endomicroscopy
34 Unknown  Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
Condition: Ovarian Cancer
35 Recruiting Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
Conditions: Hypopituitarism;   Hypogonadism;   Thyroid Dysfunction;   Bone Diseases, Metabolic
36 Unknown  LYmphadenectomy After NeoAdjuvant Chemotherapy
Condition: Advanced Ovarian Cancer (Stage III or IV) After Neoadjuvant Chemotherapy
Intervention: Procedure: Systematic pelvic and aortic lymphadenectomy
37 Recruiting Contamination of Ovarian Tissue by RT-PCR in Participants With Solid Tumors
Conditions: Minimal Residual Disease;   Fertility Preservation
Intervention: Other: malignant cells
38 Unknown  PET-CT vs. Integrated MR-PET Scanning of GYN Cancers
Conditions: Cervical Cancer;   Endometrial Cancer;   Ovarian Cancer
Interventions: Procedure: PET-CT;   Procedure: MR-PET
39 Unknown  Evaluation of Thymidine Kinase Activity in the Serum of Patients With Solid Tumors
Condition: Solid Tumors
40 Recruiting Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)
Conditions: Lung and Pleural Malignancies;   Neoplasms;   Nodules
Intervention: Drug: EC17

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Indicates status has not been verified in more than two years